AVIDITY BIOSCIENCES INC (RNA)
US05370A1088 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to RNA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 46.79. This target is 58.62% above the current price.
RNA was analyzed by 12 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about RNA.
In the previous month the buy percentage consensus was at a similar level.
RNA was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-05-10 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-05-10 | Needham | Reiterate | Buy -> Buy |
| 2024-05-03 | B of A Securities | Initiate | Buy |
| 2024-04-11 | Needham | Reiterate | Buy -> Buy |
| 2024-03-14 | Cantor Fitzgerald | Initiate | Overweight |
| 2024-03-05 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-03-04 | Needham | Reiterate | Buy -> Buy |
| 2024-02-29 | Chardan Capital | Reiterate | Buy -> Buy |
| 2024-02-29 | Needham | Reiterate | Buy -> Buy |
| 2024-01-03 | Wells Fargo | Reiterate | Overweight -> Overweight |
| 2023-11-29 | Needham | Reiterate | Buy -> Buy |
| 2023-08-09 | Chardan Capital | Maintains | Buy -> Buy |
| 2023-08-09 | Needham | Reiterate | Buy -> Buy |
| 2023-08-09 | Credit Suisse | Reiterate | Outperform -> Outperform |
| 2023-05-22 | Evercore ISI Group | Upgrade | In-Line -> Outperform |
| 2023-05-17 | Needham | Reiterate | Buy -> Buy |
| 2023-05-11 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2023-05-10 | Credit Suisse | Reiterate | Outperform |
| 2023-04-28 | Needham | Reiterate | Buy |
| 2023-03-31 | Chardan Capital | Reiterate | Buy |
| 2023-03-31 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2023-03-31 | Credit Suisse | Maintains | Outperform |
| 2023-03-01 | Chardan Capital | Reiterate | Buy |
| 2023-03-01 | Needham | Reiterate | Buy |
| 2023-03-01 | Credit Suisse | Reiterate | Outperform |
| 2023-01-04 | Wells Fargo | Maintains | Overweight |
| 2022-12-15 | Raymond James | Maintains | Strong Buy |
| 2022-12-15 | Credit Suisse | Maintains | Outperform |
| 2022-12-14 | Raymond James | Maintains | Strong Buy |
| 2022-11-09 | Raymond James | Maintains | Strong Buy |